Free public records show Medacta International SA in 3 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Medacta International SA or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
32 active studies led by Medacta International SA, of 60 in all
Source: ClinicalTrials.gov, Studies with Medacta International SA (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
156 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
14 recalls since 2015 (14 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Studies Medacta International SA leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Medacta International SA or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Medacta International SA: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Medacta International SA is in.
Stories on the topics Medacta International SA works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
ReadSearch all reports for Medacta International SA All companies